MARKET

ANAB

ANAB

AnaptysBio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

44.12
+1.28
+2.99%
After Hours: 44.12 0 0.00% 16:32 09/13 EDT
OPEN
43.39
PREV CLOSE
42.84
HIGH
44.93
LOW
42.99
VOLUME
259.44K
TURNOVER
--
52 WEEK HIGH
110.00
52 WEEK LOW
38.53
MARKET CAP
1.19B
P/E (TTM)
-14.7081
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ANAB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ANAB News

  • Biotech Stock On The Radar: Aimmune Awaits Adcom Test
  • Benzinga.4d ago
  • The Week Ahead In Biotech: Cardiology, Analyst Conferences In The Spotlight
  • Benzinga.09/02 19:19
  • The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved
  • Benzinga.08/28 11:31
  • The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend
  • Benzinga.08/25 19:06

More

Industry

Biotechnology & Medical Research
+0.20%
Pharmaceuticals & Medical Research
-0.38%

Hot Stocks

Name
Price
%Change

About ANAB

AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product pipeline includes ANB020 and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. The Company's ANB020 product candidate is an antibody that inhibits the activity of interleukin-33, and is used for the treatment of severe adult asthma and severe adult peanut allergy. In addition, the Company is engaged in developing its ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustular psoriasis (PPP).
More

Webull offers AnaptysBio Inc (ANAB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.